McKay, R. R., Tang, M., Zhang, J., Todoric, J., Imai, K., Azad, A. (2026). IDeate-Prostate01: A phase 3, randomized, open-label study of ifinatamab deruxtecan versus docetaxel in participants with previously treated metastatic castration-resistant prostate cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.tps294